Lista de obras -

"Before Xpert I only had my expertise": A qualitative study on the utilization and effects of Xpert technology among pediatricians in 4 Indian cities.

artículo científico publicado en 2018

A multisite assessment of the quantitative capabilities of the Xpert MTB/RIF assay

artículo científico publicado en 2011

Accelerating access to quality TB care for pediatric TB cases through better diagnostic strategy in four major cities of India.

artículo científico publicado en 2018

Accuracy of the Xpert MTB/RIF test for the diagnosis of pulmonary tuberculosis in children admitted to hospital in Cape Town, South Africa: a descriptive study

artículo científico publicado en 2011

Addressing the challenges of diagnostics demand and supply: insights from an online global health discussion platform

artículo científico publicado en 2016

Aiming for zero tuberculosis transmission in low-burden countries

artículo científico publicado en 2017

Alignment of new tuberculosis drug regimens and drug susceptibility testing: a framework for action

artículo científico publicado en 2013

An Appeal to the Global Health Community for a Tripartite Innovation: An "Essential Diagnostics List," "Health in All Policies," and "See-Through 21(st) Century Science and Ethics".

artículo científico publicado en 2015

Analytical and Clinical Evaluation of the Epistem Genedrive Assay for Detection of Mycobacterium tuberculosis

artículo científico publicado en 2016

Application of a simple point-of-care test to reduce UK healthcare costs and adverse events in outpatient acute respiratory infections

scientific article published on 07 April 2020

Assessment of the sensitivity and specificity of Xpert MTB/RIF assay as an early sputum biomarker of response to tuberculosis treatment

artículo científico publicado en 2013

Catalysing progressive uptake of newer diagnostics by health care providers through outreach and education in four major cities of India.

artículo científico publicado en 2018

Catching the missing million: experiences in enhancing TB & DR-TB detection by providing upfront Xpert MTB/RIF testing for people living with HIV in India

artículo científico publicado en 2015

Comparative accuracy of the REBA MTB MDR and Hain MTBDRplus line probe assays for the detection of multidrug-resistant tuberculosis: A multicenter, non-inferiority study

artículo científico publicado en 2017

Comparative performance of four rapid Ebola antigen-detection lateral flow immunoassays during the 2014-2016 Ebola epidemic in West Africa

artículo científico publicado en 2019

Containment of bioaerosol infection risk by the Xpert MTB/RIF assay and its applicability to point-of-care settings.

artículo científico publicado en 2010

Cost and operational impact of promoting upfront GeneXpert MTB/RIF test referrals for presumptive pediatric tuberculosis patients in India

article

Defining the needs for next generation assays for tuberculosis

artículo científico publicado en 2015

Determine TB-LAM lateral flow urine antigen assay for HIV-associated tuberculosis: recommendations on the design and reporting of clinical studies

artículo científico publicado en 2013

Development, roll-out and impact of Xpert MTB/RIF for tuberculosis: what lessons have we learnt and how can we do better?

artículo científico publicado en 2016

Diagnosis of opportunistic infections: HIV co-infections - tuberculosis

artículo científico publicado en 2017

Diagnostic preparedness for infectious disease outbreaks

artículo científico

Early depletion of Mycobacterium tuberculosis-specific T helper 1 cell responses after HIV-1 infection

scientific article published on December 2008

Eliminating the Neglected Tropical Diseases: Translational Science and New Technologies

artículo científico publicado en 2016

Enhancing TB case detection: experience in offering upfront Xpert MTB/RIF testing to pediatric presumptive TB and DR TB cases for early rapid diagnosis of drug sensitive and drug resistant TB

artículo científico publicado en 2014

Evaluation of Xpert MTB/RIF for detection of tuberculosis from blood samples of HIV-infected adults confirms Mycobacterium tuberculosis bacteremia as an indicator of poor prognosis

artículo científico publicado en 2013

Evaluation of genotype MTBDRsl assay to detect drug resistance associated with fluoroquinolones, aminoglycosides and ethambutol on clinical sediments

artículo científico publicado en 2012

Factors Associated with Tuberculosis and Rifampicin-Resistant Tuberculosis amongst Symptomatic Patients in India: A Retrospective Analysis

artículo científico publicado en 2016

Feasibility and Operational Performance of Tuberculosis Detection by Loop-Mediated Isothermal Amplification Platform in Decentralized Settings: Results from a Multicenter Study

artículo científico publicado en 2016

Feasibility of decentralised deployment of Xpert MTB/RIF test at lower level of health system in India

artículo científico publicado en 2014

Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study

artículo científico publicado en 2011

Impact of Xpert MTB/RIF for TB diagnosis in a primary care clinic with high TB and HIV prevalence in South Africa: a pragmatic randomised trial

artículo científico publicado en 2014

Importance of diagnostics in epidemic and pandemic preparedness

Multicenter Noninferiority Evaluation of Hain GenoType MTBDRplus Version 2 and Nipro NTM+MDRTB Line Probe Assays for Detection of Rifampin and Isoniazid Resistance

artículo científico publicado en 2016

Need to confirm isoniazid susceptibility in Xpert MTB/RIF rifampin susceptible cases.

artículo científico publicado en 2012

Operational feasibility of using loop-mediated isothermal amplification for diagnosis of pulmonary tuberculosis in microscopy centers of developing countries

artículo científico publicado en 2007

Piloting Upfront Xpert MTB/RIF Testing on Various Specimens under Programmatic Conditions for Diagnosis of TB & DR-TB in Paediatric Population

artículo científico publicado en 2015

Rapid Molecular Detection of Extrapulmonary Tuberculosis by the Automated GeneXpert MTB/RIF System ⬇️

artículo científico publicado el 26 de enero de 2011

Rapid and accurate detection of Mycobacterium tuberculosis in sputum samples by Cepheid Xpert MTB/RIF assay--a clinical validation study

artículo científico publicado en 2011

Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology

artículo científico publicado en 2009

Rapid diagnosis of tuberculosis with the Xpert MTB/RIF assay in high burden countries: a cost-effectiveness analysis

artículo científico publicado en 2011

Rapid molecular diagnosis of pulmonary tuberculosis in children using nasopharyngeal specimens

artículo científico publicado en 2012

Robustness of a loop-mediated isothermal amplification reaction for diagnostic applications

artículo científico publicado en 2011

Target product profile of a molecular drug-susceptibility test for use in microscopy centers

artículo científico publicado en 2015

The Potential Impact of Up-Front Drug Sensitivity Testing on India's Epidemic of Multi-Drug Resistant Tuberculosis

artículo científico publicado en 2015

The changing landscape of diagnostic services for tuberculosis

artículo científico publicado en 2013

Transforming TB diagnosis: can patients and control programs afford to wait?

artículo científico publicado en 2012

Tuberculosis Diagnostics in the New Millennium: Role in TB Identification and Control

artículo científico publicado en 2012

Tuberculosis Diagnostics: State of the Art and Future Directions

artículo científico publicado en 2016

Use of Xpert MTB/RIF in Decentralized Public Health Settings and Its Effect on Pulmonary TB and DR-TB Case Finding in India

artículo científico publicado en 2015

Xpert MTB/RIF assay for the diagnosis of extrapulmonary tuberculosis: a systematic review and meta-analysis

artículo científico publicado en 2014

Xpert MTB/RIF test for detection of pulmonary tuberculosis and rifampicin resistance

artículo científico publicado en 2012

Xpert MTB/RIF: a new pillar in diagnosis of extrapulmonary tuberculosis?

artículo científico publicado en 2011

Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults

artículo científico publicado en 2014

Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults

artículo científico publicado en 2013

Lista de obras de

"Before Xpert I only had my expertise": A qualitative study on the utilization and effects of Xpert technology among pediatricians in 4 Indian cities.

A multisite assessment of the quantitative capabilities of the Xpert MTB/RIF assay

Accelerating access to quality TB care for pediatric TB cases through better diagnostic strategy in four major cities of India.

Accuracy of the Xpert MTB/RIF test for the diagnosis of pulmonary tuberculosis in children admitted to hospital in Cape Town, South Africa: a descriptive study

Addressing the challenges of diagnostics demand and supply: insights from an online global health discussion platform

Aiming for zero tuberculosis transmission in low-burden countries

Alignment of new tuberculosis drug regimens and drug susceptibility testing: a framework for action

An Appeal to the Global Health Community for a Tripartite Innovation: An "Essential Diagnostics List," "Health in All Policies," and "See-Through 21(st) Century Science and Ethics".

Analytical and Clinical Evaluation of the Epistem Genedrive Assay for Detection of Mycobacterium tuberculosis

Application of a simple point-of-care test to reduce UK healthcare costs and adverse events in outpatient acute respiratory infections

Assessment of the sensitivity and specificity of Xpert MTB/RIF assay as an early sputum biomarker of response to tuberculosis treatment

Catalysing progressive uptake of newer diagnostics by health care providers through outreach and education in four major cities of India.

Catching the missing million: experiences in enhancing TB & DR-TB detection by providing upfront Xpert MTB/RIF testing for people living with HIV in India

Comparative accuracy of the REBA MTB MDR and Hain MTBDRplus line probe assays for the detection of multidrug-resistant tuberculosis: A multicenter, non-inferiority study

Comparative performance of four rapid Ebola antigen-detection lateral flow immunoassays during the 2014-2016 Ebola epidemic in West Africa

Containment of bioaerosol infection risk by the Xpert MTB/RIF assay and its applicability to point-of-care settings.

Cost and operational impact of promoting upfront GeneXpert MTB/RIF test referrals for presumptive pediatric tuberculosis patients in India

Defining the needs for next generation assays for tuberculosis

Determine TB-LAM lateral flow urine antigen assay for HIV-associated tuberculosis: recommendations on the design and reporting of clinical studies

Development, roll-out and impact of Xpert MTB/RIF for tuberculosis: what lessons have we learnt and how can we do better?

Diagnosis of opportunistic infections: HIV co-infections - tuberculosis

Diagnostic preparedness for infectious disease outbreaks

Early depletion of Mycobacterium tuberculosis-specific T helper 1 cell responses after HIV-1 infection

Eliminating the Neglected Tropical Diseases: Translational Science and New Technologies

Enhancing TB case detection: experience in offering upfront Xpert MTB/RIF testing to pediatric presumptive TB and DR TB cases for early rapid diagnosis of drug sensitive and drug resistant TB

Evaluation of Xpert MTB/RIF for detection of tuberculosis from blood samples of HIV-infected adults confirms Mycobacterium tuberculosis bacteremia as an indicator of poor prognosis

Evaluation of genotype MTBDRsl assay to detect drug resistance associated with fluoroquinolones, aminoglycosides and ethambutol on clinical sediments

Factors Associated with Tuberculosis and Rifampicin-Resistant Tuberculosis amongst Symptomatic Patients in India: A Retrospective Analysis

Feasibility and Operational Performance of Tuberculosis Detection by Loop-Mediated Isothermal Amplification Platform in Decentralized Settings: Results from a Multicenter Study

Feasibility of decentralised deployment of Xpert MTB/RIF test at lower level of health system in India

Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study

Impact of Xpert MTB/RIF for TB diagnosis in a primary care clinic with high TB and HIV prevalence in South Africa: a pragmatic randomised trial

Importance of diagnostics in epidemic and pandemic preparedness

Multicenter Noninferiority Evaluation of Hain GenoType MTBDRplus Version 2 and Nipro NTM+MDRTB Line Probe Assays for Detection of Rifampin and Isoniazid Resistance

Need to confirm isoniazid susceptibility in Xpert MTB/RIF rifampin susceptible cases.

Operational feasibility of using loop-mediated isothermal amplification for diagnosis of pulmonary tuberculosis in microscopy centers of developing countries

Piloting Upfront Xpert MTB/RIF Testing on Various Specimens under Programmatic Conditions for Diagnosis of TB & DR-TB in Paediatric Population

Rapid Molecular Detection of Extrapulmonary Tuberculosis by the Automated GeneXpert MTB/RIF System ⬇️

Rapid and accurate detection of Mycobacterium tuberculosis in sputum samples by Cepheid Xpert MTB/RIF assay--a clinical validation study

Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology

Rapid diagnosis of tuberculosis with the Xpert MTB/RIF assay in high burden countries: a cost-effectiveness analysis

Rapid molecular diagnosis of pulmonary tuberculosis in children using nasopharyngeal specimens

Robustness of a loop-mediated isothermal amplification reaction for diagnostic applications

Target product profile of a molecular drug-susceptibility test for use in microscopy centers

The Potential Impact of Up-Front Drug Sensitivity Testing on India's Epidemic of Multi-Drug Resistant Tuberculosis

The changing landscape of diagnostic services for tuberculosis

Transforming TB diagnosis: can patients and control programs afford to wait?

Tuberculosis Diagnostics in the New Millennium: Role in TB Identification and Control

Tuberculosis Diagnostics: State of the Art and Future Directions

Use of Xpert MTB/RIF in Decentralized Public Health Settings and Its Effect on Pulmonary TB and DR-TB Case Finding in India

Xpert MTB/RIF assay for the diagnosis of extrapulmonary tuberculosis: a systematic review and meta-analysis

Xpert MTB/RIF test for detection of pulmonary tuberculosis and rifampicin resistance

Xpert MTB/RIF: a new pillar in diagnosis of extrapulmonary tuberculosis?

Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults

Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults